Alamar Biosciences Inc. (ALMR)
NASDAQ: ALMRIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ALMR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.84B
- EPS (TTM)
- -$1.13
- Dividend yield
- None
- 52-week range
- 18.85 – 39.61
- Day range
- 26.24 – 28.22
- Volume / Avg
- 712.58K / 628.70K
- Beta
- —
- Shares outstanding
- 69.48M
52-week range
ALMR stock today
Shares of Alamar Biosciences (ALMR) finished lower on Nov 20 at $26.48, a drop of 7.67% or $2.20 per share, versus the S&P 500's 3.70% decline. At this level, ALMR sits in the middle of its 52-week range of $18.85 to $39.61: 33.1% below the high, set on Oct 6, 2026 and 40.5% above the low. Alamar Biosciences has posted a net loss over the last twelve months (EPS of -$1.13), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Alamar Biosciences
Company profileAlamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics.
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- CEO
- Dr. Yuling Luo Ph.D.
- Headquarters
- Fremont, CA
- Employees
- 308
- IPO year
- 2026
- Website
- alamarbio.com
Analyst forecast
ForecastConsensus (5 analysts)
buy
Avg. price target
$37.00+39.73%
- Strong buy 1
- Buy 3
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 3, 2026
- EPS actual vs est.
- $-0.19 vs $-0.22
- Surprise
- +13.64%
ALMR news
All ALMR news- JAMA Study Using Alamar Biosciences’ NULISA Assay Links Blood eMTBR-tau to Tau tangle Burden in Former Football Players with Advanced CTEGlobeNewswire
- Alamar Biosciences Highlights NULISA Data in 46 Presentations at CTAD 2026, Including 10 Oral PresentationsGlobeNewswire
- Alamar Biosciences to Participate in Upcoming Investor ConferencesGlobeNewswire
- Alamar Biosciences (ALMR) Q3 2026 Earnings Call TranscriptNasdaq
- Alamar Biosciences Reports Third Quarter 2026 Financial Results and Raises 2026 Revenue GuidanceGlobeNewswire
- Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision MedicineGlobeNewswire
- UPDATE -- Alamar Biosciences and Nightingale Health to Lead UK Biobank 80,000-Sample Neurodegenerative Disease StudyGlobeNewswire
- Alamar Biosciences' Protein Signature Detects ALS With 98.3% Accuracy In StudyNasdaqALMR, SUN
Alamar Biosciences peers
Industrials sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CTKBCytek Biosciences Inc. | 6.12 | -3.16% | $800.40M | vs ALMR |
| PACBPacific Biosciences of California Inc. | 1.63 | -7.39% | $508.95M | vs ALMR |
| NAUTNautilus Biotechnology Inc. | 2.12 | -2.30% | $270.03M | vs ALMR |
| LABStandard BioTools Inc. | 0.631 | +2.82% | $249.11M | vs ALMR |
| QTRXQuanterix Corporation | 1.96 | -3.45% | $93.06M | vs ALMR |
| SEERSeer Inc. Class A | 1.36 | -1.81% | $75.91M | vs ALMR |
| HBIOHarvard Bioscience Inc. | 8.66 | -0.23% | $39.60M | vs ALMR |
| RPIDRapid Micro Biosystems Inc. Class A | 0.735 | -0.04% | $37.37M | vs ALMR |
Indexes, lists and sector
Alamar Biosciences stock FAQ
What is Alamar Biosciences's stock price today?
ALMR last traded at $26.48 as of Nov 20, 4:00 PM EST, down 7.67% on the day. Prices are delayed at least 15 minutes.
Who is Alamar Biosciences's CEO?
Dr. Yuling Luo Ph.D. is the chief executive officer of Alamar Biosciences Inc., which has about 308 employees.
What is the ALMR 52-week high?
The 52-week high for ALMR is $39.61 and the 52-week low is $18.85. The stock is currently 33.1% below its high.